FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31992211000001104: Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    96950201000001119 Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    96950301000001111 Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Is a Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has specific active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has specific active ingredient Norgestimate false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) 63 tablet Has AMP False Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start